Search results
What if I can't find a doctor? Physician shortage will change how Americans receive care.
USA TODAY Opinion via Yahoo News· 4 days agoFDA approval may help burst Big Pharma myths. Making it easier for patients to take their medicines...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 6 days agoBelbuca prescriptions grew 3.2% in the previous quarter and a similar trend is likely to have driven...
CONSUMER PROTECTION ALERT FOR SILVERSCRIPT PART D MEMBERS: A Class Action Lawsuit Has Been Filed...
FOX 59 Indianapolis· 1 day agoThe law firms of Kessler Topaz Meltzer & Check, LLP and Carella, Byrne, Cecchi, Brody & Agnello,...
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 4 days agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 14 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 14 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
Turning 65 This Year? 6 Things You Need To Do Now for Retirement
GoBankingRates via AOL· 17 hours agoSixty-five is a magic age for many retirees. You're finally eligible for Medicare and can get higher...
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 days agoThis increase in gross-to-net deductions in the first quarter of 2024 is primarily related to higher Medicare Part D and PHS expenses ...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 4 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 4 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...